![]() Representatives from Moderna and Johnson & Johnson did not respond to requests for comment. ![]() “This is a large and concerning number of negative health impacts,” Siri said of ICAN's conclusions, adding that he's aware of no comparable public data for other vaccines.Ī Pfizer media representative in an email said that the company’s vaccine has “a favorable safety profile and high level of protection against severe COVID-19 disease and hospitalization.” In addition, another CDC spokesperson said that agency personnel made follow-up calls to any v-safe users who reported seeking medical attention.īut ICAN counsel Aaron Siri of Siri & Glimstad, who led the FOIA litigation against the agency, said that because some vaccine-related adverse effects (chronic arthritis, thrombocytopenia, Guillain-Barré syndrome, myocarditis and more) can appear weeks after vaccination, it's important to broaden the time frame beyond the one-week window in research the CDC cited. She pointed me to a report looking at the first six months of v-safe data to back up the assertion. In the first week after getting the shot, the spokesperson continued, "reports of seeking any medical care (including telehealth appointments) range from 1-3% (depending on vaccine, age group and dose)." The CDC "cannot comment on analyses conducted outside of the agency that we have not seen," the spokesperson said via email, but added that v-safe data "have shown low rates of medical care after vaccination, particularly hospitalization." Most of the participants were White adults, with a mean age of 65.I asked a CDC spokesperson what the agency made of ICAN's calculations. ![]() ![]() The researchers analyzed data on 928 adults who self-reported what symptoms they experienced after receiving Pfizer/BioNTech or Moderna Covid-19 vaccinations, as well as submitted a dried blood spot to test for antibodies. “This is more to reassure people who have had a reaction that that’s their immune system responding, actually in a rather good way, to the vaccine, even though it has caused them some discomfort,” Schaffner said. William Schaffner, a professor in the Division of Infectious Diseases at Vanderbilt University Medical Center and medical director of the National Foundation for Infectious Diseases, who was not involved in the new study. The vaccine didn’t work.’ I don’t want that conclusion to be out there,” said Dr. “I don’t want a patient to tell me that, ‘Golly, I didn’t get any reaction, my arm wasn’t sore, I didn’t have fever. Nearly all study participants exhibited a positive antibody response after completing a two-dose Pfizer/BioNTech or Moderna vaccine series. Scott Olson/Getty Imagesįirst on CNN: More Americans are getting their booster shots, but 'it's not enough,' Biden administration warnsīut even though some people may have small, localized side effects or no symptoms at all, the vaccine still elicits robust immune responses in them too. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on Septemin Chicago, Illinois.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |